Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents-Reference-Cited by-同舟云学术

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents

Published:2010-06-30 Issue:1 Volume:19 Page:1-14
ISSN:1226-2560
Container-title:Experimental Neurobiology
language:en
Short-container-title:Exp Neurobiol

Author:

Youdim Moussa B. H.¹

Affiliation:

1. Eve Topf and US National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases, Technion-Faculty of Medicine, Efron St., Haifa 31096, Israel, Department of Biology, Yonsei Uinversity, Seoul 120-749, Korea

Publisher

The Korean Society for Brain and Neural Science

Subject

Cellular and Molecular Neuroscience,Clinical Neurology

Link

https://synapse.koreamed.org/pdf/10.5607/en.2010.19.1.1

Reference84 articles.

1. Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator?monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease

2. Regulation of Bcl‐2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine

3. Familial Parkinson's Disease: Possible Role of Environmental Factors

4. Monoamine oxidase B inhibition and neuroprotection: Studies on selective adenosine A2A receptor antagonists

5. 8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics;Nutrients;2023-06-16

2. Relevance of Biochemical Deep Phenotyping for a Personalised Approach to Parkinson’s Disease;Neuroscience;2023-02

3. Brain-protective mechanisms of autophagy associated circRNAs: Kick starting self-cleaning mode in brain cells via circRNAs as a potential therapeutic approach for neurodegenerative diseases;Frontiers in Molecular Neuroscience;2023-01-16

4. Exploring links between 2‐oxoglutarate‐dependent oxygenases and Alzheimer's disease;Alzheimer's & Dementia;2022-07-19

5. 8-Hydroxyquinolines: A Promising Pharmacophore Potentially Developed as Disease-Modifying Agents for Neurodegenerative Diseases: A Review;HETEROCYCLES;2022